483
Chemtron Biotech, IncFDA 483 - Chemtron Biotech, Inc - March 18, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Chemtron Biotech, Inc. in San Diego, CA, conducted from March 14-18, 2022, identified a significant issue regarding process validation. The firm failed to adequately validate a manufacturing process, specifically by not performing operational qualification for equipment used in producing in-vitro diagnostic test kits. This lapse indicates a potential risk to the quality and reliability of their finished IVD products.
Open in Dashboard
ID · 0a1eec23-3b69-4a67-94be-93b5756c5af0